The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global GBS (Group B Streptococcus) Testing Market Research Report 2025
Synopsis
The scientific name of GBS is Streptococcus agalactiae, also known as group B Streptococcus. It normally lives in the vagina and rectum. It is an opportunistic pathogenic bacteria. Invasive infections are most common in neonates, the elderly, and those with predisposing factors (i.e., pregnancy, diabetes, and immunocompromise). Generally, GBS infection in normal healthy people does not cause illness.According to research, about 10% to 30% of pregnant women have GBS vaginally resident, and 40% to 70% of them will be passed to their newborns during delivery. If newborns carry GBS, about 1% to 3% will develop early invasive infection, of which 5% will lead to death. Infections in pregnant women manifest as bacteremia, urinary tract infection, fetal membrane infection, endometrial infection and wound infection.
The global GBS (Group B Streptococcus) Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for GBS (Group B Streptococcus) Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for GBS (Group B Streptococcus) Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of GBS (Group B Streptococcus) Testing include Zhuhai DL Biotech, Meikang Biotechnology, Biomerieux, Shandong Boko Biotechnology, Barrett Bio, Luminex, Guangdong Sunshine Biotechnology, Shengxiang Biotechnology and Borcheng, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for GBS (Group B Streptococcus) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GBS (Group B Streptococcus) Testing.
Report Scope
The GBS (Group B Streptococcus) Testing market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global GBS (Group B Streptococcus) Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GBS (Group B Streptococcus) Testing manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zhuhai DL Biotech
Meikang Biotechnology
Biomerieux
Shandong Boko Biotechnology
Barrett Bio
Luminex
Guangdong Sunshine Biotechnology
Shengxiang Biotechnology
Borcheng
Guangzhou Huaao Biotechnology
Kayudi Biotechnology
Suzhou Tianlong Biotechnology
Beijing KingWolf Biology
Guangzhou Micron Biotechnology
Shanghai Suchuang Diagnostic Products
Certest Biotec S.L.
Thermo Fisher
AtilaBiosystems
Segment by Type
Microbiological Culture Method
Fluorescence Quantitative PCR Method
Immunochromatography
Other
Segment by Application
Newborn
Elderly
Pregnant Woman
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of GBS (Group B Streptococcus) Testing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of GBS (Group B Streptococcus) Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The scientific name of GBS is Streptococcus agalactiae, also known as group B Streptococcus. It normally lives in the vagina and rectum. It is an opportunistic pathogenic bacteria. Invasive infections are most common in neonates, the elderly, and those with predisposing factors (i.e., pregnancy, diabetes, and immunocompromise). Generally, GBS infection in normal healthy people does not cause illness.According to research, about 10% to 30% of pregnant women have GBS vaginally resident, and 40% to 70% of them will be passed to their newborns during delivery. If newborns carry GBS, about 1% to 3% will develop early invasive infection, of which 5% will lead to death. Infections in pregnant women manifest as bacteremia, urinary tract infection, fetal membrane infection, endometrial infection and wound infection.
The global GBS (Group B Streptococcus) Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for GBS (Group B Streptococcus) Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for GBS (Group B Streptococcus) Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of GBS (Group B Streptococcus) Testing include Zhuhai DL Biotech, Meikang Biotechnology, Biomerieux, Shandong Boko Biotechnology, Barrett Bio, Luminex, Guangdong Sunshine Biotechnology, Shengxiang Biotechnology and Borcheng, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for GBS (Group B Streptococcus) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GBS (Group B Streptococcus) Testing.
Report Scope
The GBS (Group B Streptococcus) Testing market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global GBS (Group B Streptococcus) Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GBS (Group B Streptococcus) Testing manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zhuhai DL Biotech
Meikang Biotechnology
Biomerieux
Shandong Boko Biotechnology
Barrett Bio
Luminex
Guangdong Sunshine Biotechnology
Shengxiang Biotechnology
Borcheng
Guangzhou Huaao Biotechnology
Kayudi Biotechnology
Suzhou Tianlong Biotechnology
Beijing KingWolf Biology
Guangzhou Micron Biotechnology
Shanghai Suchuang Diagnostic Products
Certest Biotec S.L.
Thermo Fisher
AtilaBiosystems
Segment by Type
Microbiological Culture Method
Fluorescence Quantitative PCR Method
Immunochromatography
Other
Segment by Application
Newborn
Elderly
Pregnant Woman
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of GBS (Group B Streptococcus) Testing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of GBS (Group B Streptococcus) Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 GBS (Group B Streptococcus) Testing Market Overview
1.1 Product Overview and Scope of GBS (Group B Streptococcus) Testing
1.2 GBS (Group B Streptococcus) Testing Segment by Type
1.2.1 Global GBS (Group B Streptococcus) Testing Market Value Comparison by Type (2024-2030)
1.2.2 Microbiological Culture Method
1.2.3 Fluorescence Quantitative PCR Method
1.2.4 Immunochromatography
1.2.5 Other
1.3 GBS (Group B Streptococcus) Testing Segment by Application
1.3.1 Global GBS (Group B Streptococcus) Testing Market Value by Application: (2024-2030)
1.3.2 Newborn
1.3.3 Elderly
1.3.4 Pregnant Woman
1.3.5 Other
1.4 Global GBS (Group B Streptococcus) Testing Market Size Estimates and Forecasts
1.4.1 Global GBS (Group B Streptococcus) Testing Revenue 2019-2030
1.4.2 Global GBS (Group B Streptococcus) Testing Sales 2019-2030
1.4.3 Global GBS (Group B Streptococcus) Testing Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 GBS (Group B Streptococcus) Testing Market Competition by Manufacturers
2.1 Global GBS (Group B Streptococcus) Testing Sales Market Share by Manufacturers (2019-2024)
2.2 Global GBS (Group B Streptococcus) Testing Revenue Market Share by Manufacturers (2019-2024)
2.3 Global GBS (Group B Streptococcus) Testing Average Price by Manufacturers (2019-2024)
2.4 Global GBS (Group B Streptococcus) Testing Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of GBS (Group B Streptococcus) Testing, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of GBS (Group B Streptococcus) Testing, Product Type & Application
2.7 GBS (Group B Streptococcus) Testing Market Competitive Situation and Trends
2.7.1 GBS (Group B Streptococcus) Testing Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest GBS (Group B Streptococcus) Testing Players Market Share by Revenue
2.7.3 Global GBS (Group B Streptococcus) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 GBS (Group B Streptococcus) Testing Retrospective Market Scenario by Region
3.1 Global GBS (Group B Streptococcus) Testing Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global GBS (Group B Streptococcus) Testing Global GBS (Group B Streptococcus) Testing Sales by Region: 2019-2030
3.2.1 Global GBS (Group B Streptococcus) Testing Sales by Region: 2019-2024
3.2.2 Global GBS (Group B Streptococcus) Testing Sales by Region: 2025-2030
3.3 Global GBS (Group B Streptococcus) Testing Global GBS (Group B Streptococcus) Testing Revenue by Region: 2019-2030
3.3.1 Global GBS (Group B Streptococcus) Testing Revenue by Region: 2019-2024
3.3.2 Global GBS (Group B Streptococcus) Testing Revenue by Region: 2025-2030
3.4 North America GBS (Group B Streptococcus) Testing Market Facts & Figures by Country
3.4.1 North America GBS (Group B Streptococcus) Testing Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America GBS (Group B Streptococcus) Testing Sales by Country (2019-2030)
3.4.3 North America GBS (Group B Streptococcus) Testing Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe GBS (Group B Streptococcus) Testing Market Facts & Figures by Country
3.5.1 Europe GBS (Group B Streptococcus) Testing Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe GBS (Group B Streptococcus) Testing Sales by Country (2019-2030)
3.5.3 Europe GBS (Group B Streptococcus) Testing Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific GBS (Group B Streptococcus) Testing Market Facts & Figures by Country
3.6.1 Asia Pacific GBS (Group B Streptococcus) Testing Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific GBS (Group B Streptococcus) Testing Sales by Country (2019-2030)
3.6.3 Asia Pacific GBS (Group B Streptococcus) Testing Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America GBS (Group B Streptococcus) Testing Market Facts & Figures by Country
3.7.1 Latin America GBS (Group B Streptococcus) Testing Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America GBS (Group B Streptococcus) Testing Sales by Country (2019-2030)
3.7.3 Latin America GBS (Group B Streptococcus) Testing Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa GBS (Group B Streptococcus) Testing Market Facts & Figures by Country
3.8.1 Middle East and Africa GBS (Group B Streptococcus) Testing Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa GBS (Group B Streptococcus) Testing Sales by Country (2019-2030)
3.8.3 Middle East and Africa GBS (Group B Streptococcus) Testing Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global GBS (Group B Streptococcus) Testing Sales by Type (2019-2030)
4.1.1 Global GBS (Group B Streptococcus) Testing Sales by Type (2019-2024)
4.1.2 Global GBS (Group B Streptococcus) Testing Sales by Type (2025-2030)
4.1.3 Global GBS (Group B Streptococcus) Testing Sales Market Share by Type (2019-2030)
4.2 Global GBS (Group B Streptococcus) Testing Revenue by Type (2019-2030)
4.2.1 Global GBS (Group B Streptococcus) Testing Revenue by Type (2019-2024)
4.2.2 Global GBS (Group B Streptococcus) Testing Revenue by Type (2025-2030)
4.2.3 Global GBS (Group B Streptococcus) Testing Revenue Market Share by Type (2019-2030)
4.3 Global GBS (Group B Streptococcus) Testing Price by Type (2019-2030)
5 Segment by Application
5.1 Global GBS (Group B Streptococcus) Testing Sales by Application (2019-2030)
5.1.1 Global GBS (Group B Streptococcus) Testing Sales by Application (2019-2024)
5.1.2 Global GBS (Group B Streptococcus) Testing Sales by Application (2025-2030)
5.1.3 Global GBS (Group B Streptococcus) Testing Sales Market Share by Application (2019-2030)
5.2 Global GBS (Group B Streptococcus) Testing Revenue by Application (2019-2030)
5.2.1 Global GBS (Group B Streptococcus) Testing Revenue by Application (2019-2024)
5.2.2 Global GBS (Group B Streptococcus) Testing Revenue by Application (2025-2030)
5.2.3 Global GBS (Group B Streptococcus) Testing Revenue Market Share by Application (2019-2030)
5.3 Global GBS (Group B Streptococcus) Testing Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Zhuhai DL Biotech
6.1.1 Zhuhai DL Biotech Corporation Information
6.1.2 Zhuhai DL Biotech Description and Business Overview
6.1.3 Zhuhai DL Biotech GBS (Group B Streptococcus) Testing Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Zhuhai DL Biotech GBS (Group B Streptococcus) Testing Product Portfolio
6.1.5 Zhuhai DL Biotech Recent Developments/Updates
6.2 Meikang Biotechnology
6.2.1 Meikang Biotechnology Corporation Information
6.2.2 Meikang Biotechnology Description and Business Overview
6.2.3 Meikang Biotechnology GBS (Group B Streptococcus) Testing Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Meikang Biotechnology GBS (Group B Streptococcus) Testing Product Portfolio
6.2.5 Meikang Biotechnology Recent Developments/Updates
6.3 Biomerieux
6.3.1 Biomerieux Corporation Information
6.3.2 Biomerieux Description and Business Overview
6.3.3 Biomerieux GBS (Group B Streptococcus) Testing Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Biomerieux GBS (Group B Streptococcus) Testing Product Portfolio
6.3.5 Biomerieux Recent Developments/Updates
6.4 Shandong Boko Biotechnology
6.4.1 Shandong Boko Biotechnology Corporation Information
6.4.2 Shandong Boko Biotechnology Description and Business Overview
6.4.3 Shandong Boko Biotechnology GBS (Group B Streptococcus) Testing Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Shandong Boko Biotechnology GBS (Group B Streptococcus) Testing Product Portfolio
6.4.5 Shandong Boko Biotechnology Recent Developments/Updates
6.5 Barrett Bio
6.5.1 Barrett Bio Corporation Information
6.5.2 Barrett Bio Description and Business Overview
6.5.3 Barrett Bio GBS (Group B Streptococcus) Testing Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Barrett Bio GBS (Group B Streptococcus) Testing Product Portfolio
6.5.5 Barrett Bio Recent Developments/Updates
6.6 Luminex
6.6.1 Luminex Corporation Information
6.6.2 Luminex Description and Business Overview
6.6.3 Luminex GBS (Group B Streptococcus) Testing Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Luminex GBS (Group B Streptococcus) Testing Product Portfolio
6.6.5 Luminex Recent Developments/Updates
6.7 Guangdong Sunshine Biotechnology
6.6.1 Guangdong Sunshine Biotechnology Corporation Information
6.6.2 Guangdong Sunshine Biotechnology Description and Business Overview
6.6.3 Guangdong Sunshine Biotechnology GBS (Group B Streptococcus) Testing Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Guangdong Sunshine Biotechnology GBS (Group B Streptococcus) Testing Product Portfolio
6.7.5 Guangdong Sunshine Biotechnology Recent Developments/Updates
6.8 Shengxiang Biotechnology
6.8.1 Shengxiang Biotechnology Corporation Information
6.8.2 Shengxiang Biotechnology Description and Business Overview
6.8.3 Shengxiang Biotechnology GBS (Group B Streptococcus) Testing Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Shengxiang Biotechnology GBS (Group B Streptococcus) Testing Product Portfolio
6.8.5 Shengxiang Biotechnology Recent Developments/Updates
6.9 Borcheng
6.9.1 Borcheng Corporation Information
6.9.2 Borcheng Description and Business Overview
6.9.3 Borcheng GBS (Group B Streptococcus) Testing Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Borcheng GBS (Group B Streptococcus) Testing Product Portfolio
6.9.5 Borcheng Recent Developments/Updates
6.10 Guangzhou Huaao Biotechnology
6.10.1 Guangzhou Huaao Biotechnology Corporation Information
6.10.2 Guangzhou Huaao Biotechnology Description and Business Overview
6.10.3 Guangzhou Huaao Biotechnology GBS (Group B Streptococcus) Testing Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Guangzhou Huaao Biotechnology GBS (Group B Streptococcus) Testing Product Portfolio
6.10.5 Guangzhou Huaao Biotechnology Recent Developments/Updates
6.11 Kayudi Biotechnology
6.11.1 Kayudi Biotechnology Corporation Information
6.11.2 Kayudi Biotechnology GBS (Group B Streptococcus) Testing Description and Business Overview
6.11.3 Kayudi Biotechnology GBS (Group B Streptococcus) Testing Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Kayudi Biotechnology GBS (Group B Streptococcus) Testing Product Portfolio
6.11.5 Kayudi Biotechnology Recent Developments/Updates
6.12 Suzhou Tianlong Biotechnology
6.12.1 Suzhou Tianlong Biotechnology Corporation Information
6.12.2 Suzhou Tianlong Biotechnology GBS (Group B Streptococcus) Testing Description and Business Overview
6.12.3 Suzhou Tianlong Biotechnology GBS (Group B Streptococcus) Testing Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Suzhou Tianlong Biotechnology GBS (Group B Streptococcus) Testing Product Portfolio
6.12.5 Suzhou Tianlong Biotechnology Recent Developments/Updates
6.13 Beijing KingWolf Biology
6.13.1 Beijing KingWolf Biology Corporation Information
6.13.2 Beijing KingWolf Biology GBS (Group B Streptococcus) Testing Description and Business Overview
6.13.3 Beijing KingWolf Biology GBS (Group B Streptococcus) Testing Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Beijing KingWolf Biology GBS (Group B Streptococcus) Testing Product Portfolio
6.13.5 Beijing KingWolf Biology Recent Developments/Updates
6.14 Guangzhou Micron Biotechnology
6.14.1 Guangzhou Micron Biotechnology Corporation Information
6.14.2 Guangzhou Micron Biotechnology GBS (Group B Streptococcus) Testing Description and Business Overview
6.14.3 Guangzhou Micron Biotechnology GBS (Group B Streptococcus) Testing Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Guangzhou Micron Biotechnology GBS (Group B Streptococcus) Testing Product Portfolio
6.14.5 Guangzhou Micron Biotechnology Recent Developments/Updates
6.15 Shanghai Suchuang Diagnostic Products
6.15.1 Shanghai Suchuang Diagnostic Products Corporation Information
6.15.2 Shanghai Suchuang Diagnostic Products GBS (Group B Streptococcus) Testing Description and Business Overview
6.15.3 Shanghai Suchuang Diagnostic Products GBS (Group B Streptococcus) Testing Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Shanghai Suchuang Diagnostic Products GBS (Group B Streptococcus) Testing Product Portfolio
6.15.5 Shanghai Suchuang Diagnostic Products Recent Developments/Updates
6.16 Certest Biotec S.L.
6.16.1 Certest Biotec S.L. Corporation Information
6.16.2 Certest Biotec S.L. GBS (Group B Streptococcus) Testing Description and Business Overview
6.16.3 Certest Biotec S.L. GBS (Group B Streptococcus) Testing Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Certest Biotec S.L. GBS (Group B Streptococcus) Testing Product Portfolio
6.16.5 Certest Biotec S.L. Recent Developments/Updates
6.17 Thermo Fisher
6.17.1 Thermo Fisher Corporation Information
6.17.2 Thermo Fisher GBS (Group B Streptococcus) Testing Description and Business Overview
6.17.3 Thermo Fisher GBS (Group B Streptococcus) Testing Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Thermo Fisher GBS (Group B Streptococcus) Testing Product Portfolio
6.17.5 Thermo Fisher Recent Developments/Updates
6.18 AtilaBiosystems
6.18.1 AtilaBiosystems Corporation Information
6.18.2 AtilaBiosystems GBS (Group B Streptococcus) Testing Description and Business Overview
6.18.3 AtilaBiosystems GBS (Group B Streptococcus) Testing Sales, Revenue and Gross Margin (2019-2024)
6.18.4 AtilaBiosystems GBS (Group B Streptococcus) Testing Product Portfolio
6.18.5 AtilaBiosystems Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 GBS (Group B Streptococcus) Testing Industry Chain Analysis
7.2 GBS (Group B Streptococcus) Testing Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 GBS (Group B Streptococcus) Testing Production Mode & Process
7.4 GBS (Group B Streptococcus) Testing Sales and Marketing
7.4.1 GBS (Group B Streptococcus) Testing Sales Channels
7.4.2 GBS (Group B Streptococcus) Testing Distributors
7.5 GBS (Group B Streptococcus) Testing Customers
8 GBS (Group B Streptococcus) Testing Market Dynamics
8.1 GBS (Group B Streptococcus) Testing Industry Trends
8.2 GBS (Group B Streptococcus) Testing Market Drivers
8.3 GBS (Group B Streptococcus) Testing Market Challenges
8.4 GBS (Group B Streptococcus) Testing Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
